JINLING PHARM.
0009196.261.13% ( +0.07 )
JINLING PHARM. (000919)
Jinling Pharmaceutical Company Limited, together with its subsidiaries, manufactures and sells pharmaceuticals and medical devices in China and internationally....
- Open
- 6.19
- High
- 6.26
- Low
- 6.17
- Prev. Close
- 6.19
- Volume
- 60.64K
- Turnover
- 37.77M
- Avg Price
- 6.23
- Bid/Ask Ratio
- --
- Amplitude
- 1.45%
- 52wk High
- 9.70
- Volume Ratio
- 0.64
- Turnover Ratio
- 0.98%
JINLING PHARM. Analyst Rating
View MoreForecast & Rating
Oct 29, 2018Price forecast
¥8.9943.84%
Forecast & RatingStrong buy
1analysts
- Strong buy100.00%
- Buy0.00%
- Hold0.00%
- Sell0.00%
- Strong sell0.00%
News
- Wallstreetcn · Apr 14 at 10:30 PM
April 15 Midday Market Review: GEM Index Opens High and Falls, Closing Down 0.23%; Innovative Drug Concepts Rally Collectively
- Wallstreetcn · Apr 9 at 03:19 AM
A-share Three Major Indices Fell Collectively, Computing Hardware Active Against the Trend, Hang Seng Tech Index Down Over 1%, AI Large Model Stocks Rebound, KNOWLEDGE ATLAS Rises 7%
- Zhitong · Oct 27, 2025 at 05:06 AM
JINLING PHARM.: Net profit in the third quarter was 20.1248 million yuan, a year-on-year decrease of 1.84%
- Zhitong · Sep 3, 2025 at 04:18 AM
JINLING PHARM.: Olaratumab tablets approved to conduct Phase III clinical research
- Zhitong · Aug 25, 2025 at 05:27 AM
JINLING PHARM.: The holding subsidiary has received approval for the listing of potassium sulfate
- Zhitong · Aug 20, 2025 at 03:25 AM
JINLING PHARM.: Fuzhou Meifeng Pharmaceutical Factory's hydrolyzed protein injection has received re-registration approval
